health
Minnesota nonprofit hospitals spent millions overseas
Tax-exempt hospitals in Minnesota that have raked in large sums of revenue from a government safety net program spent tens of millions of dollars overseas over the past fiscal year, raising alarm among watchdogs monitoring the flow of cash in the nonprofit healthcare sector.
TL;DR
- Minnesota's tax-exempt hospitals participating in the 340B drug discount program generated at least $1.34 billion in net revenue in 2024.
- These hospitals collectively spent billions abroad, with significant amounts stashed in offshore accounts in the Caribbean, Central America, and Europe.
- The 340B program allows providers to purchase drugs at discounted prices and receive reimbursements, but there are no strict federal or state requirements on how this revenue is used.
- Audits by the Minnesota Department of Health have highlighted challenges in accurately tracing reimbursements for office-administered drugs and inconsistencies in reporting methods, leading to concerns about transparency.
- Critics, including consumer advocacy groups, suggest that some providers may be exploiting the 340B program to fund activities unrelated to patient care, such as diversity, equity, and inclusion initiatives or gender-transition treatments.
- There are concerns that hospitals may be inflating internal costs or miscategorizing expenses to appear as though less 340B revenue is generated.
- Studies indicate that many charitable organizations spend less on charity care than they receive in tax breaks, leading to accusations that they are undeserving of their tax-exempt status.